… Conflict of interest: TMA Wilkinson reports grants and personal fees from GSK and AZ;
grants and personal fees from MMH, of which he is a company director; personal fees and …

Chronic obstructive pulmonary disease (COPD) remains a leading cause of morbidity and
mortality despite current treatment strategies which focus on smoking cessation, pulmonary …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries
a substantial risk of severe and prolonged illness; treatment options are currently limited. …

Treatment of chronic obstructive pulmonary disease (COPD) exacerbations improves
outcomes; however, responses to treatment are variable, and patients with COPD often delay …

Computed tomography (CT) is the modality of choice for imaging the thorax and lung
structure. In chronic obstructive pulmonary disease (COPD), it used to recognise the key …

Study objectives Patients with COPD experience lower airway and systemic inflammation,
and an accelerated decline in FEV 1 . There is no evidence on whether this inflammation …

Impact: This study explores the use of measuring plasma biomarkers at exacerbation of
chronic obstructive pulmonary disease (COPD), providing insight into the underlying …

Rationale: Frequent chronic obstructive pulmonary disease (COPD) exacerbations are a
major cause of hospital admission and mortality and are associated with increased airway …

Relationships between high-resolution computed tomography (HRCT) findings in chronic
obstructive pulmonary disease (COPD) and bacterial colonization, airway inflammation, or …

Chronic obstructive pulmonary disease (COPD) exacerbations are associated with increased
airway and systemic inflammation, though relationships between exacerbation recovery, …